this post was submitted on 28 Apr 2024
57 points (100.0% liked)

Health - Resources and discussion for everything health-related

2341 readers
256 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 1 year ago
MODERATORS
 

The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B who meet certain requirements.

The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. 

The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B who meet certain requirements.

The treatment will be available by prescription to eligible patients this quarter, a Pfizer spokesperson told CNBC. It has a hefty $3.5 million price tag, before insurance and other rebates, the spokesperson added, making it by far one of the most expensive drugs in the U.S.

top 6 comments
sorted by: hot top controversial new old
[–] [email protected] 3 points 6 months ago (1 children)

It should be illegal for any drug to be this expensive.

[–] [email protected] 2 points 6 months ago

Don't worry! I'm sure Pfizer hasn't gotten any of our tax money to develop this drug, so I'm sure it's just about recovering costs to make a modest profit!

[–] [email protected] 3 points 6 months ago (1 children)

BEQVEZ is a one-time treatment that is designed to enable people living with hemophilia B to produce FIX themselves rather than the current standard of care, which requires regular intravenous infusions of FIX that are often administered multiple times a week or multiple times a month.1,2

A 2021 study found that the cost for an adult’s lifetime treatmentTrusted Source of moderately severe to severe hemophilia B averages $22,987,483 million for preventive FIX treatment and $20,971,826 for on-demand FIX treatment. --https://www.healthline.com/health/hemophilia-treatment#costs

[–] [email protected] 4 points 6 months ago (1 children)

Ooh, I think I remember reading somewhere that these patients have to be moved around insurance pools in the US just to keep the insurance industry working, lol. Because they're so expensive. I guess 3.5 is less than 20.

[–] [email protected] 1 points 6 months ago

But, it's actually even so much better because it's supposed to work as a one time cure. So, in addition to smaller price tag all of the ongoing stress and coordination for the patients and the system just evaporates! So wonderful if it works.

[–] [email protected] 2 points 6 months ago

This is great, hear me out.

First stuff doesnt work well and are expensive.

Then they get normal, works better and are less expensive.

And in the end they work perfectly well and cost almost nothing.

Cellphones is a good example but there are loads of others. So yeah, it's expensive but will pave the way for cheap good treatment in the future.